Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.
- DOI
- 10.1136/bmjment-2023-300728
- Published
- 2023 Jul
- Container
- BMJ mental health
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjment-2023-300728,
title = {Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.},
author = {Tardelli V and Xu KY and Bisaga A and Levin FR and Fidalgo TM and Grucza RA},
year = {2023},
journal = {BMJ mental health},
doi = {10.1136/bmjment-2023-300728},
url = {https://doi.org/10.1136/bmjment-2023-300728}
}RIS
TY - JOUR TI - Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk. AU - Tardelli V AU - Xu KY AU - Bisaga A AU - Levin FR AU - Fidalgo TM AU - Grucza RA PY - 2023 JO - BMJ mental health DO - 10.1136/bmjment-2023-300728 UR - https://doi.org/10.1136/bmjment-2023-300728 ER -
APA
V, T., KY, X., A, B., FR, L., TM, F., & RA, G. (2023). Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.. BMJ mental health. https://doi.org/10.1136/bmjment-2023-300728
Source records
- pubmed · retrieved 2026-09-27T13:23:09.561Z
- europe-pmc · retrieved 2026-09-27T13:23:09.578Z